Investec Bank plc has filed a Form 8.5 regulatory disclosure revealing significant share dealings in Advanced Medical Solutions Group Plc (AMS.L) on 2nd July 2026.
The disclosure was made under Rule 8.5 of the Takeover Code, which governs public dealing disclosures by exempt principal traders with recognised intermediary status.
Investec Bank plc acted in a client-serving capacity during the transactions, as required to be declared under the relevant provisions of the Takeover Code.
The bank holds a dual role in relation to Advanced Medical Solutions Group Plc (AMS.L), serving as both adviser and joint broker to the company at the time of the dealings.
On the purchases side, Investec Bank acquired a total of 1,975,000 ordinary shares in Advanced Medical Solutions Group Plc (AMS.L) during the disclosed dealing period.
The purchase prices for those ordinary shares ranged from a low of 280.25 pence per unit to a high of 281 pence per unit.
On the sales side, Investec Bank disposed of 1,597,487 ordinary shares, with prices also ranging between 280.25 pence and 281 pence per unit.
No cash-settled derivative transactions, stock-settled derivative transactions, or options were reported as part of this disclosure filing.
Investec Bank confirmed there are no indemnity arrangements, option agreements, or understandings that may have served as an inducement to deal or refrain from dealing.
The bank similarly confirmed no agreements exist relating to voting rights or future acquisition and disposal of securities to which any derivative is referenced.
The disclosure was formally dated 3rd July 2026 and submitted in accordance with regulatory requirements for public disclosure under Rule 8 of the Takeover Code.
Contact for the disclosure was listed as Priyali Bhattacharjee, with a telephone number provided for enquiries relating to the filing.
